|
Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia
|
Jul 2012
|
Pediatr Blood Cancer
|
aplastic anemia
|
|
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Jul 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplantation in severe aplastic anemia
|
Jul 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
A promising new treatment for refractory aplastic anemia
|
Jul 2012
|
N Engl J Med
|
aplastic anemia
|
|
Eltrombopag and improved hematopoiesis in refractory aplastic anemia
|
Jul 2012
|
N Engl J Med
|
aplastic anemia
|
|
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated?
|
Jul 2012
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Successful Use of Eculizumab in a Pediatric Patient Treated for Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2012
|
J Pediatr Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations.
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "myelodysplastic syndromes: challenges to improving patient and caregiver satisfaction"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
